IRCT20210213050344N1招募中3 期
Investigation of the Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 Patients, Shiraz City, Southern Iran, 2020: A Randomized Controlled Trial Study (RCT)
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 375
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years(—)
- 性别
- All
入选标准
- •Clients to selected outpatient treatment centers in Shiraz
- •Only mild symptoms and clinical manifestations (including: fever less than 38 degrees, sore throat with or without dry cough, chills, headache, loss of taste and smell, nausea, vomiting, anorexia, diarrhea, body aches, weakness and Excessive fatigue, persistent yard symptoms)
- •Positive RT-PCR test result
- •Age between 18 and 80 years
- •People with underlying disease (to evaluate the effectiveness of the drug on people with underlying disease)
- •Individuals who have completed and signed the written consent to participate in the project
- •Blood oxygen level 93% and above (O2 sat = 93%)
排除标准
- •Pregnant mothers
- •Breastfeeding mothers
- •Severe liver disease
- •Severe kidney disease
- •Severe lung disease
- •HIV Positive patients
- •Chronic obstructive pulmonary disease (COPD)
- •Participate in another RCT
- •Dissatisfaction with participating in the study
研究者
相似试验
招募中
不适用
Efficacy of Ivermectin in the treatment of COVID-19IRCT20210901052358N4Shahid Beheshti University of Medical Sciences60
招募中
2 期
Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20200408046987N2Akam Tejarat Fartak Farasoo150
已完成
2 期
Evaluating the effect of Ivermectin on covid 19 patientsCOVID 19.Corona virus infection, unspecifiedU07.1IRCT20200404046937N4Ahvaz University of Medical Sciences60
尚未招募
不适用
â??To study the effectiveness of Ivermectin with standard of care treatmentversus standard of care treatment for COVID 19 cases. A Pilot StudyCTRI/2020/04/024858Max Super Speciality Hospital A Unit of Devki Devi Foundation
尚未招募
2 期
Study to assess efficacy of Ivermectin as prophylaxis of COVID -19CTRI/2020/05/025333R D Gardi Medical College
